| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2.79M | 84.4% | $8.00 | +$22.3M |
| Sells | 3 | -518K | 15.6% | $13.14 | -$6.8M |
| Net | -2 | +2.27M | 68.7% | +$15.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GSK plc | 10%+ Owner | $134M | +$22.3M | +20% | Sep 27, 2024 |
| Ken Takanashi | Director, 10%+ Owner | $14.2M | Aug 12, 2024 | ||
| Paul Bolno | President and CEO, Director | $3.26M | -$3.12M | -48.9% | Nov 25, 2024 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | $459K | Jul 22, 2024 | ||
| Gregory L. Verdine | Director | $114K | Aug 12, 2024 | ||
| Kyle Moran | Chief Financial Officer | $111K | -$251K | -69.3% | Oct 11, 2024 |
| Mark Corrigan | Director | $79.9K | Aug 12, 2024 | ||
| Heidi Wagner | Director | $79.9K | Aug 12, 2024 | ||
| Ra Capital Management, L.P. | Director, 10%+ Owner | $40K | Aug 12, 2024 | ||
| Christian O. Henry | Director | $40K | Aug 12, 2024 | ||
| Adrian Rawcliffe | Director | $40K | Aug 12, 2024 | ||
| Aik Na Tan | Director | $40K | Aug 12, 2024 | ||
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | $0 | -$3.43M | -100% | Nov 8, 2024 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | Jul 25, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|